Skip to main content
Premium Trial:

Request an Annual Quote

Eddy Rubin, Joseph (Jay) Mohr, Richard Shea, Raymond Withy

Premium

Eddy Rubin has been appointed acting director and acting division director of the genomics division of the Joint Genome Institute at Lawrence Berkeley National Lab, as the JGI searches for a permanent director to replace Trevor Hawkins.

Hawkins has stepped down to become Amersham’s senior vice president for genomics.

Rubin is currently a senior scientist and head of genome sciences at Berkeley labs. His research focuses on biological annotation of mammalian genomes and using expression profiling to identify regulatory gene sequences.

Hawkins is gradually reducing his involvement at JGI as he moves into the Amersham position. His title at JGI is now consulting director. Institute representatives have said that they hope to identify a replacement by the summer.

 

Pharmacogenomics and diagnostics company Variagenics has appointed Joseph (Jay) Mohr, formerly its vice president of marketing and business development, as its new CEO. Mohr replaces Taylor Crouch, who has resigned. Richard Shea, the company’s chief financial officer, will assume the newly created position of chief operating officer.

 

Raymond Withy has begun his tenure as CEO at monoclonal antibody company Abgenix, replacing current CEO Scott Greer. Withy, formerly the company’s president and chief operating officer, has also served as chief business officer and vice president of corporate development at the company, as well as director of business development at Cell Genesys, of which Abgenix is a spin-off. Prior to these positions, Withy also worked in research and development at Genzyme and Integrated Genetics. Withy received his PhD in biochemistry from the University of Nottingham in the UK, and completed a postdoctoral fellowship at Cal Tech.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.